| ANAs | Antinuclear Antibodies |
| AS | Ankylosing Spondylitis |
| ATRA | All-Trans Retinoic Acid |
| CHC | Chronic Hyperplastic Candidiasis |
| CMC | Chronic Mucocutaneous Candidiasis |
| COVID-19 | Coronavirus Disease |
| cGVHD | Chronic Graft Versus Host Disease |
| DIF | Direct Immunofluorescence |
| EBER | Epstein–Barr Virus-encoded small RNA |
| EBV | Epstein–Barr Virus |
| EEM | Erythema Exudativum Multiforme |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| ENAs | Extractable Nuclear Antigens |
| FDA | Food and Drug Administration |
| GERD | Gastro-Oesophageal Reflux Disease |
| HIV | Human Immunodeficiency Virus |
| IBD | Inflammatory Bowel Disease |
| IL-17 | Interleukin 17 |
| IL-17A | Interleukin 17-A |
| IL-23 | Interleukin 23 |
| LE | Lupus Erythematosus |
| MRONJ | Medication-Related Osteonecrosis of the Jaw |
| MS | Multiple Sclerosis |
| NHL | Non-Hodgkin Lymphoma |
| OLDR | Oral Lichenoid Drug Reaction |
| OLP | Oral Lichen Planus |
| OLR | Oral Lichenoid Reaction |
| OPMD | Oral Potentially Malignant Disorder |
| PAS | Periodic Acid-Schiff |
| PCI | Percutaneous Coronary Intervention |
| PHD | Histopathological Diagnosis |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PsA | Psoriatic Arthritis |
| PsO | Psoriasis |
| QoL | Quality of Life |
| RA | Rheumatoid Arthritis |
| SEC | Secukinumab |
| TNF-α | Tumour Necrosis Factor-α |
| WHO | World Health Organization |